With around 40 species spread throughout temperate and subtropical environments, mostly in East Asia and North America, the genus Lespedeza (Fabaceae) includes a variety of species that have been used in traditional folk medicine for centuries. Particularly in antioxidant, anti-inflammatory, anticancer, and antidiabetic applications, Lespedeza species show notable pharmacological promise, due in large part to their high polyphenolic content. With a 2,2-diphenyl-1-picrylhydrazyl (DPPH) IC50 of 20–25 µg/mL and a ferric ion reducing antioxidant power (FRAP) value of 819.5 µmol Fe2+/g, L. cuneata demonstrated the highest antioxidant activity among the three Lespedeza species. The rich polyphenolic profile includes quercetin, catechin, rutin, and special substances like lespeflorin B/C and lespecunioside A/B, which explain its efficacy. Its broad-spectrum action across DPPH, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and nitric oxide (NO) tests points to its importance for neuroprotective and anti-aging uses. Anti-inflammatory studies support its capacity to downregulate tumor necrosis factor (TNF-α) and interleukin 6 (IL-6) via nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) suppression. L. bicolor has shown excellent promise, owing to its high total flavonoid content (109.2 mg QE/g) and presence of bioactives including kaempferol-3-O-rutinoside and xanthoangelol, albeit displaying somewhat lower antioxidant capacity (FRAP: 912.3 µmol Fe2+/g). In macrophage models it showed clear anti-inflammatory action. Its capacity to prevent advanced glycation end products’ (AGEs) generation ties it to possible antidiabetic and antiaging effects. Although it showed the worst antioxidant profile (IC50: 40–60 µg/mL; FRAP: 743.2 µmol Fe2+/g), L. capitata nonetheless had useful components like quercetin, chlorogenic acid, and lespedecapitoside (syn. isoorientin). Though little researched, they have modest antioxidant, nephroprotective, and anti-inflammatory action.